These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 24292792)
1. Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response. Zeng J; Wang S Stem Cells Transl Med; 2014 Jan; 3(1):69-80. PubMed ID: 24292792 [TBL] [Abstract][Full Text] [Related]
2. Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cells by CD1d overexpression. Zeng J; Shahbazi M; Wu C; Toh HC; Wang S J Immunol; 2012 May; 188(9):4297-304. PubMed ID: 22407918 [TBL] [Abstract][Full Text] [Related]
3. Olea europaea pollen lipids activate invariant natural killer T cells by upregulating CD1d expression on dendritic cells. Abós-Gracia B; del Moral MG; López-Relaño J; Viana-Huete V; Castro L; Villalba M; Martínez-Naves E J Allergy Clin Immunol; 2013 May; 131(5):1393-9.e5. PubMed ID: 23265858 [TBL] [Abstract][Full Text] [Related]
4. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner. Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315 [TBL] [Abstract][Full Text] [Related]
5. Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines. Lameris R; Schneiders FL; de Gruijl TD; van der Vliet HJ Methods Mol Biol; 2014; 1139():155-65. PubMed ID: 24619678 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses. Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323 [TBL] [Abstract][Full Text] [Related]
7. Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein. Das R; Guan P; Wiener SJ; Patel NP; Gohl TG; Evans E; Zauderer M; Nichols KE Blood Adv; 2019 Mar; 3(5):813-824. PubMed ID: 30858151 [TBL] [Abstract][Full Text] [Related]
8. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. Paquin-Proulx D; Gibbs A; Bächle SM; Checa A; Introini A; Leeansyah E; Wheelock CE; Nixon DF; Broliden K; Tjernlund A; Moll M; Sandberg JK J Immunol; 2016 Sep; 197(5):1843-51. PubMed ID: 27481843 [TBL] [Abstract][Full Text] [Related]
9. CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity. Li Y; Zhao C; Liu J; Lu Z; Lu M; Gu J; Liu R Oncol Rep; 2019 May; 41(5):2679-2688. PubMed ID: 30864713 [TBL] [Abstract][Full Text] [Related]
10. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells. Lawson V Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667 [TBL] [Abstract][Full Text] [Related]
11. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide. Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753 [TBL] [Abstract][Full Text] [Related]
12. On/off TLR signaling decides proinflammatory or tolerogenic dendritic cell maturation upon CD1d-mediated interaction with invariant NKT cells. Caielli S; Conforti-Andreoni C; Di Pietro C; Usuelli V; Badami E; Malosio ML; Falcone M J Immunol; 2010 Dec; 185(12):7317-29. PubMed ID: 21078913 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma. Escribà-Garcia L; Alvarez-Fernández C; Tellez-Gabriel M; Sierra J; Briones J J Transl Med; 2017 May; 15(1):115. PubMed ID: 28549432 [TBL] [Abstract][Full Text] [Related]
14. CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy. Hara A; Koyama-Nasu R; Takami M; Toyoda T; Aoki T; Ihara F; Kobayashi M; Hirono S; Matsutani T; Nakayama T; Iwadate Y; Motohashi S Cancer Immunol Immunother; 2021 May; 70(5):1239-1254. PubMed ID: 33128583 [TBL] [Abstract][Full Text] [Related]
15. A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer. Seki T; Liu J; Brutkiewicz RR; Tsuji M Anticancer Res; 2019 Feb; 39(2):549-555. PubMed ID: 30711929 [TBL] [Abstract][Full Text] [Related]
16. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction. Gentilini MV; Pérez ME; Fernández PM; Fainboim L; Arana E Cancer Immunol Immunother; 2016 May; 65(5):551-62. PubMed ID: 26969612 [TBL] [Abstract][Full Text] [Related]
17. Murine CD8 Oh S; Lee H; Shin JH; Hong C; Park SH Immunol Invest; 2018 Jan; 47(1):89-100. PubMed ID: 29099628 [TBL] [Abstract][Full Text] [Related]
18. Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional. Sun W; Wang Y; East JE; Kimball AS; Tkaczuk K; Kesmodel S; Strome SE; Webb TJ Cytokine; 2015 Mar; 72(1):48-57. PubMed ID: 25569376 [TBL] [Abstract][Full Text] [Related]
19. Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus). Fichtner AS; Paletta D; Starick L; Schumann RF; Niewiesk S; Herrmann T Immunology; 2015 Dec; 146(4):618-29. PubMed ID: 26346465 [TBL] [Abstract][Full Text] [Related]
20. A single amino acid defines cross-species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells. Zhang P; Li D; Stewart-Jones G; Shao X; Zhang Y; Chen Q; Li Y; He YW; Xu XN; Zhang HT Immunology; 2009 Dec; 128(4):500-10. PubMed ID: 19863613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]